-
Mashup Score: 2Science - 8 day(s) ago
Our immune system is our best defense against diseases, as it recognizes and destroys diseased cells. But sometimes, this defense does not work as intended when diseased cells manage to hide from immune cells or when the immune system turns against the body. Our proprietary ImmTAX (Immune Mobilizing Monoclonal TCRs Against X disease) technology is designed to address these limitations, by activating the immune system to make infected or tumor cells visible and then destroy them, or by turning off the
Source: www.immunocore.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32Big Book of R - 10 day(s) ago
400+ Free R programming books
Source: www.bigbookofr.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol - 29 day(s) ago
Key Points. In this R/R population with high unmet need, patients responding to tabelecleucel demonstrated a clinically meaningful survival benefitTabelecl
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 44FOXO1 is a master regulator of memory programming in CAR T cells - 1 month(s) ago
Nature – The transcription factor FOXO1 has a key role in human T cell memory, and manipulating FOXO1 expression could provide a way to enhance CAR T cell therapies by increasing CAR T cell…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18
The Instrument for assessing the Credibility of Effect Modification Analyses offers explicit guidance for investigators, systematic reviewers, journal editors and others considering making a claim of effect modification or interpreting a claim made by others.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 18
The Instrument for assessing the Credibility of Effect Modification Analyses offers explicit guidance for investigators, systematic reviewers, journal editors and others considering making a claim of effect modification or interpreting a claim made by others.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30r-best-practice/cheatsheet.pdf at main · wurli/r-best-practice - 2 month(s) ago
A cheatsheet for basic best practice in R programming – wurli/r-best-practice
Source: github.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
We performed a clinical trial to evaluate safety and immunogenicity of a novel long peptide vaccine administered in combinations of incomplete Freund’s adjuvant (IFA) and agonists for TLR3 (polyICLC) and TLR7/8 (resiquimod). We hypothesized that …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Improving Your Statistical Inferences - 9 Equivalence Testing and Interval Hypotheses - 2 month(s) ago
This open educational resource contains information to improve statistical inferences, design better experiments, and report scientific research more transparently.
Source: lakens.github.ioCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 22Evolutionary trajectories of small cell lung cancer under therapy - 2 month(s) ago
Nature – We uncover key processes of the genomic evolution of small cell lung cancer under therapy, identify the common ancestor as the source of clonal diversity at relapse and show central…
Source: www.nature.comCategories: General Medicine News, Hem/OncsTweet
RT @iskander: ImmTAX (https://t.co/hSphLis5Gv) seem really neat. Is anyone else using TCR heads for BiTE/BiKE-like molecules? Or making ant…